These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1360097)

  • 21. Exosurf treatment investigational new drug phase: effect of an individualized third dose in infants with respiratory distress syndrome.
    Easa D; Pelke S; Nakamura KT; Barrett J; Balaraman V; Loo SW; Ibarra-Pratt E; Smith MB
    Pediatr Pulmonol; 1992 Sep; 14(1):16-22. PubMed ID: 1437338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double-blind, randomized, placebo-controlled Canadian multicenter trial of two doses of synthetic surfactant or air placebo in 224 infants weighing 500 to 749 grams with respiratory distress syndrome. Canadian Exosurf Neonatal Study Group.
    Smyth J; Allen A; MacMurray B; Peliowski A; Sankaran K; Volberg F; Shukla A; Long W
    J Pediatr; 1995 May; 126(5 Pt 2):S81-9. PubMed ID: 7745516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Instillation rate effects of Exosurf on cerebral and cardiovascular haemodynamics in preterm neonates.
    Saliba E; Nashashibi M; Vaillant MC; Nasr C; Laugier J
    Arch Dis Child Fetal Neonatal Ed; 1994 Nov; 71(3):F174-8. PubMed ID: 7820712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome at 1-year adjusted age of 957 infants weighing more than 1250 grams with respiratory distress syndrome randomized to receive synthetic surfactant or air placebo. American and Canadian Exosurf Neonatal Study Groups.
    Sauve R; Long W; Vincer M; Bard H; Derleth D; Stevenson D; Pauly T; Robertson C
    J Pediatr; 1995 May; 126(5 Pt 2):S75-80. PubMed ID: 7745515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. One-year outcome in 232 premature infants with birth weights of 750 to 1249 grams and respiratory distress syndrome randomized to rescue treatment with two doses of synthetic surfactant or air placebo. Canadian Exosurf Neonatal Study Group.
    Saigal S; Robertson C; Sankaran K; Bingham W; Casiro O; MacMurray B; Whitfield M; Long W
    J Pediatr; 1995 May; 126(5 Pt 2):S61-7. PubMed ID: 7745513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of two rescue doses of synthetic surfactant in 344 infants with respiratory distress syndrome weighing 750 to 1249 grams: a double-blind, placebo-controlled multicenter Canadian trial. Canadian Exosurf Neonatal Study Group.
    McMillan D; Chernick V; Finer N; Schiff D; Bard H; Watts J; Krzeski R; Long W
    J Pediatr; 1995 May; 126(5 Pt 2):S90-8. PubMed ID: 7745517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. One-year follow-up evaluation of 260 premature infants with respiratory distress syndrome and birth weights of 700 to 1350 grams randomized to two rescue doses of synthetic surfactant or air placebo. American Exosurf Neonatal Study Group I.
    Gong A; Anday E; Boros S; Bucciarelli R; Burchfield D; Zucker J; Long W
    J Pediatr; 1995 May; 126(5 Pt 2):S68-74. PubMed ID: 7745514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of intra-amniotic administration of Exosurf in preterm rabbit fetuses.
    Galan HL; Kuehl TJ
    Obstet Gynecol; 1992 Oct; 80(4):604-8. PubMed ID: 1407880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indomethacin pharmacodynamics are altered by surfactant: a possible challenge to current indomethacin dosing guidelines created before surfactant availability.
    McPherson C; Gal P; Ransom JL; Carlos RQ; Dimaguila MA; Smith M; Davonzo C; Wimmer JE
    Pediatr Cardiol; 2010 May; 31(4):505-10. PubMed ID: 20063159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Natural or synthetic surfactant in the treatment of neonatal respiratory distress syndrome].
    Robertson B; Sangstad OD
    Tidsskr Nor Laegeforen; 1994 Feb; 114(5):590-1. PubMed ID: 8209345
    [No Abstract]   [Full Text] [Related]  

  • 31. Double-blind, randomized trial of one versus three prophylactic doses of synthetic surfactant in 826 neonates weighing 700 to 1100 grams: effects on mortality rate. American Exosurf Neonatal Study Groups I and IIa.
    Corbet A; Gerdes J; Long W; Avila E; Puri A; Rosenberg A; Edwards K; Cook L
    J Pediatr; 1995 Jun; 126(6):969-78. PubMed ID: 7776110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single dose surfactant rescue therapy in neonatal respiratory distress syndrome.
    Sanghvi KP; Merchant RH
    Indian Pediatr; 1998 Jun; 35(6):533-6. PubMed ID: 10216648
    [No Abstract]   [Full Text] [Related]  

  • 33. Pump administration of exogenous surfactant: effects on oxygenation, heart rate, and chest wall movement of premature infants.
    Sitler CG; Turnage CS; McFadden BE; Smith EO; Adams JM
    J Perinatol; 1993; 13(3):197-200. PubMed ID: 8345382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Artificial surfactant in the treatment of near drowning.
    McBrien M; Katumba JJ; Mukhtar AI
    Lancet; 1993 Dec; 342(8885):1485-6. PubMed ID: 7902498
    [No Abstract]   [Full Text] [Related]  

  • 35. Surfactant administration in severe hypoxic respiratory failure due to respiratory syncytial virus.
    Gebara BM; Kroupa-Kulik M
    Clin Pediatr (Phila); 1999 Apr; 38(4):253-4. PubMed ID: 10326183
    [No Abstract]   [Full Text] [Related]  

  • 36. [Exosurf-Neonatal: the synthetic surfactant. Introductory symposium, 20 June 1992].
    Monatsschr Kinderheilkd; 1992 Sep; 140(9 [EXOSURF]):1-12. PubMed ID: 1406736
    [No Abstract]   [Full Text] [Related]  

  • 37. One-year follow-up of 66 premature infants weighing 500 to 699 grams treated with a single dose of synthetic surfactant or air placebo at birth: results of a double-blind trial. American Exosurf Neonatal Study Group I.
    Walther FJ; Mullett M; Schumacher R; Sundell H; Easa D; Long W
    J Pediatr; 1995 May; 126(5 Pt 2):S13-9. PubMed ID: 7745506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cerebral blood flow velocity after surfactant instillation in preterm infants].
    Latini G
    Pediatr Med Chir; 1991; 13(4):439-40. PubMed ID: 1754482
    [No Abstract]   [Full Text] [Related]  

  • 39. Postnatal changes in pulmonary mechanics and energetics of infants with respiratory distress syndrome following surfactant treatment.
    Bhutani VK; Bowen FW; Sivieri EM
    Biol Neonate; 2005; 87(4):323-31. PubMed ID: 15985755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized trial comparing natural and synthetic surfactant: increased infection rate after natural surfactant?
    Speer CP; Robertson B; Halliday HL
    Acta Paediatr; 2000 May; 89(5):510-2. PubMed ID: 10852182
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.